STOCK TITAN

BTQ Technologies Deepens Quantum Research and Product Commercialization Expertise with the Addition of Dr. Peter Rohde

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
BTQ Technologies adds Dr. Peter Rohde to its technical team, enhancing its expertise in quantum research and commercialization.
Positive
  • Dr. Peter Rohde, an accomplished quantum computer scientist, joins BTQ's technical team.
  • Dr. Rohde's deep insights into quantum computing and cryptography will fortify BTQ's position in quantum research and commercialization.
Negative
  • None.

VANCOUVER, BC, Oct. 19, 2023 /PRNewswire/ - BTQ Technologies Inc. (the "Company" or "BTQ") (NEO: BTQ) (OTCQX: BTQQF) (FSE: NG3), a global quantum technology company focused on securing mission critical networks, proudly announces the addition of Peter Rohde, an accomplished theoretical quantum computer scientist, to its world-class technical team. Dr. Rohde, currently an Honorary Senior Lecturer at Macquarie University, and Associate Investigator at the ARC Centre of Excellence for Engineered Quantum Systems, is renowned for his deep understanding of optical quantum computing, quantum networking and the economics of quantum technology.

Since beginning his academic career in 2007, Dr. Rohde has contributed to advancing progress in quantum-related fields, such as quantum computing, quantum optics and cryptography. Additionally, Dr. Rohde is the lead author of the book "The Quantum Internet", published by Cambridge University Press.

"While quantum advantage remains a long-term target for most, its implications for information security are relevant today," said Peter Rohde. "I am excited to work for BTQ, a company that operates at the intersection of two industries where I've spent the majority of my career: quantum computing and cryptography. I am excited to work on research where outcomes have immediate relevance as we prepare ourselves for the onset of the quantum era."

"Peter Rohde's expertise and deep insights into quantum computing and cryptography are invaluable assets for BTQ. His appointment underscores our commitment to leading the quantum revolution, fortifying our stronghold in quantum research and commercialization. Together, we're not just envisioning the future of quantum technology – we're actively shaping it," said Olivier Roussy Newton, CEO of BTQ.

Dr. Rohde holds a PhD in theoretical physics (quantum computation and quantum information theory) and a Bachelor of Engineering (computer systems and electrical engineering) from the University of Queensland. He is joining Prof. Gavin Brennen, BTQ's Head of Quantum Research, at the company's office located at the Quantum Terminal in Sydney and will help drive research, as well as expand BTQ's technical team in Australia.

Dr. Rohde is also a frequent co-host on BTQ's "The Quantum State," a podcast exploring the latest research and innovation in quantum computing.

About BTQ

BTQ was founded by a group of post-quantum cryptographers with an interest in addressing the urgent security threat posed by large-scale universal quantum computers. With the support of leading research institutes and universities, BTQ is combining software and hardware to safeguard critical networks using unique post-quantum services and solutions.

Connect with BTQ: Website | LinkedIn

ON BEHALF OF THE BOARD OF DIRECTORS

Olivier Roussy Newton
CEO, Chairman
For further information:
E: desk@btq.com

Bill Mitoulas
Investor Relations
T: +1.416.479.9547
E: bill@btq.com

Neither the NEO nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

This news release does not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of any of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful, including any of the securities in the United States of America. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "1933 Act") or any state securities laws and may not be offered or sold within the United States or to, or for account or benefit of, U.S. Persons (as defined in Regulation S under the 1933 Act) unless registered under the 1933 Act and applicable state securities laws, or an exemption from such registration requirements is available.

Forward Looking Information

Certain statements herein contain forward-looking statements and forward-looking information within the meaning of applicable securities laws. Such forward-looking statements or information include but are not limited to statements or information with respect to the business plans of the Company, including with respect to its research partnerships, and anticipated markets in which the Company may be listing its common shares. Forward-looking statements or information often can be identified by the use of words such as "anticipate", "intend", "expect", "plan" or "may" and the variations of these words are intended to identify forward-looking statements and information.

The Company has made numerous assumptions including among other things, assumptions about general business and economic conditions, the development of post-quantum algorithms and quantum vulnerabilities, and the quantum computing industry generally. The foregoing list of assumptions is not exhaustive.

Although management of the Company believes that the assumptions made and the expectations represented by such statements or information are reasonable, there can be no assurance that forward-looking statements or information herein will prove to be accurate. Forward-looking statements and information are based on assumptions and involve known and unknown risks which may cause actual results to be materially different from any future results, expressed or implied, by such forward-looking statements or information. These factors include risks relating to: the availability of financing for the Company; business and economic conditions in the post-quantum and encryption computing industries generally; the speculative nature of the Company's research and development programs; the supply and demand for labour and technological post-quantum and encryption technology; unanticipated events related to regulatory and licensing matters and environmental matters; changes in general economic conditions or conditions in the financial markets; changes in laws (including regulations respecting blockchains); risks related to the direct and indirect impact of COVID-19 including, but not limited to, its impact on general economic conditions, the ability to obtain financing as required, and causing potential delays to research and development activities; and other risk factors as detailed from time to time. The Company does not undertake to update any forward-looking information, except in accordance with applicable securities laws.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/btq-technologies-deepens-quantum-research-and-product-commercialization-expertise-with-the-addition-of-dr-peter-rohde-301962322.html

SOURCE BTQ Technologies Corp.

FAQ

Who is joining BTQ's technical team?

Dr. Peter Rohde, an accomplished quantum computer scientist, is joining BTQ's technical team.

What are Dr. Rohde's areas of expertise?

Dr. Rohde has deep insights into quantum computing and cryptography.

What is the significance of Dr. Rohde's appointment?

Dr. Rohde's appointment enhances BTQ's expertise in quantum research and commercialization.

Where is BTQ's office located?

BTQ's office is located at the Quantum Terminal in Sydney.

What is the focus of BTQ Technologies?

BTQ Technologies is a global quantum technology company focused on securing mission critical networks.

What is the book authored by Dr. Rohde?

Dr. Rohde is the lead author of the book 'The Quantum Internet', published by Cambridge University Press.

BTQ TECHNOLOGIES CORP

OTC:BTQQF

BTQQF Rankings

BTQQF Latest News

BTQQF Stock Data

54.65M
72.31M
36.22%
Software - Infrastructure
Technology
Link
United States of America
Vancouver